Fibroma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Conditions:   Desmoid-Type Fibromatosis;   Recurrent Desmoid-Type Fibromatosis;   Unresectable Desmoid-Type Fibromatosis Interventions:   Drug: Nirogacestat;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2019 Category: Research Source Type: clinical trials

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Conditions:   Desmoid-Type Fibromatosis;   Recurrent Desmoid-Type Fibromatosis;   Unresectable Desmoid-Type Fibromatosis Interventions:   Drug: Nirogacestat;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI);   SpringWorks Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2019 Category: Research Source Type: clinical trials